Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Ariad Pharmaceuticals Inc. buy Rathjen

Start price
€1.32
08.10.09 / 50%
Target price
€2.28
06.04.10
Performance (%)
94.02%
End price
€2.56
06.04.10
Summary
This prediction ended on 06.04.10 with a price of €2.56. With a performance of 94.02% the BUY prediction by Rathjen was a big success. Rathjen has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Ariad Pharmaceuticals Inc. - - - -
iShares Core DAX® 0.611% -2.723% 14.325% 14.359%
iShares Nasdaq 100 -0.208% 6.703% 37.781% 55.710%
iShares Nikkei 225® 1.298% 1.009% 9.641% 4.825%
iShares S&P 500 0.636% 5.035% 30.827% 48.685%

Comments by Rathjen for this prediction

In the thread Ariad Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 94.02%
Target price 2.280
Change
Ends at 06.04.10

Kaufen

EMD Serono Canada has chosen Ariad Healthcare to be its lead marketing agency for Multibionta Probiotic Multivitamin, starting with 2010 commercialization strategies and programs.

”The ability to drive high-level business strategy, combined with a track record of developing integrated, high-engagement programs, is what I value in Ariad”, says Greg Biehn, Business Unit Director, EMD Serono. ”Given a short runway from inception to launch, I needed a team that could execute and deliver results.”

Richard Marcil, General Manager, Ariad Healthcare comments: ”Multibionta is a terrific brand to work on. It’s been available in Europe for ten years, and is now the number-one multivitamin in France and the U.K. Multibionta brings innovation to a category that’s in need of it and is backed by robust science in digestive and immune system health.”

Ariad’s work on Multibionta began earlier this spring, and marketing initiatives are now being deployed in support of its retail launch. Ariad is also working alongside Rao Barrett&Welsh, Environics and M2 Universal.

About Ariad Healthcare

Ariad Healthcare is a marketing agency that exclusively supports healthcare brands, and connects consumers, patients and health professionals to brands through high-engagement, integrated communications. Ariad Healthcare is an affiliate of Ariad Custom Communications. See www.ariad.ca for more information.

About Multibionta

Multibionta Probiotic Multivitamin is a triple-layer caplet that contains a novel and proprietary combination of 3 probiotics, 12 vitamins and 10 minerals to help support digestive and immune system health. See www.multibionta.ca for more information.

Prediction Buy
Perf. (%) 94.02%
Target price 2.280
Change
Ends at 06.04.10

(Vom Mitglied beendet)

Stopped prediction by Rathjen for Ariad Pharmaceuticals Inc.

buy
Ariad Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€6.02
29.01.14
€10.00
25.02.14
6.00%
25.02.14

buy
Ariad Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€3.29
14.10.13
€5.00
18.10.13
-42.25%
18.10.13